EPHA2 and central nervous system cancer: On the other hand, high expression levels of EPHA2 in neuroblastoma [123], of EPHB1 in glioma [120], and of EPHB6, ephrin-B2 and ephrin-B3 in neuroblastoma [103] confer a better prognosis.